期刊文献+

某社区卫生站抗高血压药物使用情况分析

Analysis of the use of antihypertensive drags in a community health station
原文传递
导出
摘要 目的了解北京市怀柔区美丽家园社区卫生站抗高血压药物的使用情况及合理性。方法通过电脑软件调取门诊使用抗高血压药物的处方及高血压药物销售情况,对抗高血压药物的使用频率、种类、联合用药情况及患者每日药费等进行统计分析。结果 CCB因其疗效和安全性,是临床最常用的抗高血压药物。ARB不良反应少,使用数量仅次于CCB,且与CCB或DA联合使用较多。RB和DA很少单独用于降压,多见于联合用药。多数患者每日抗高血压药物费用低于5元。结论我社区卫生站抗高血压药物种类比较齐全、使用合理、价格经济,基本可满足高血压患者的需求。 Objective To understand the use and rationanity of antihypertensive drags in Beautiful Home Community Health Station of huairou district,Beijing. Methods Through the computer software is taken on Septemper 11,2017 to March 10,2018 outpatient prescription of antihypertensive drags and high blood pressure drug sales,against high blood pressure drug use frequency,types,combination and the patients daily expenses for medicine and so on were analyzed. Results CCB is the most community used antihypertensive drag in clinic because of its efficacy and safety.Arb has fewer adveise reactions and is second only to CCB,and it is used in combination with CCB or DA.RB and DA are rarely used alone for lowering blood pressure,often in combination. The cost of daily antihypertensive drags for most patients is less than 5 yuan.Gonelusion I have a complete range of antihypertensive drags in my community, using a reasonable price economy.So it can basically meet the needs of patients with hypertention.
作者 巴翠蓉 Ba Cuirong(Longshan Street Community Health Service Center of Huairou District, Beijing 101400, China)
出处 《首都食品与医药》 2018年第14期50-51,共2页 Capital Food Medicine
关键词 高血压 抗高血压药物 合理用药 Hypertention Dyazide The rational use of drugs
  • 相关文献

参考文献5

二级参考文献28

  • 1刘力生,王文,姚崇华.2009年基层版《中国高血压防治指南》(摘录)[J].中国医学前沿杂志(电子版),2010,2(1):60-74. 被引量:74
  • 2曲静伟,洪中立.抗高血压药物的评价与选择[J].现代实用医学,2006,18(4):283-287. 被引量:9
  • 3陈国伟,郑宗锷.现在心脏内科学[M].长沙:湖南科学技术出版社.2002.989.
  • 4Wang W, Ma L, Zhang Y, et al. The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients:rationale,design and baseline characteristics[J]..J Hum Hypertens, 2011, 25(4): 271-277.
  • 5Mancia G, Paratia G, Biloa G, et al. Blood pressure controlbythe- nifedipine GITS-telmisartan combination in patients at highcardiovascular risk:the TALENT study[J]. J Hypertens, 2011, 29(3): 600-609.
  • 6Wang JG, Kario K, Lau T, et al. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians:a scientific statement from the Asian Pacific heartassociation[J]. Hypertens Res, 2011, 34(4): 423-430.
  • 7Elliott HL, Meredith PA. Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: urther analysis of the "ACTION" database in patients with angina[J]. J Hum Hypertens, 2011, 25(1): 63-70.
  • 8ONTARGET Investigators, Yusuf S, Teo KK, et al.Telmisartan,ramipril.or both in patients at high risk for vascular events[J]. N Engl J Med, 2008, 358(15): 1547-1559.
  • 9Geng DF, Jin DM, Wu W, et al. Angiotensin receptor blockersfor prevention of new-onset type 2 diabetes: a meta- analysis of 59862 patients[J]. Int J Cardiol, 2012, 155(2): 236- 242.
  • 10胡大一.高血压的立体化管理[J].中国医学导刊,2013,15(91:1373-1374.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部